Reduced ALKBH5 levels in pancreatic cancer tissues were identified through various technologies, and survival analysis indicated a significant association between ALKBH5 expression and poor prognosis in patients with pancreatic cancer [158, 171]. This evidence concerns the gene ALKBH5 and familial pancreatic carcinoma.